Phase 2 N=100 Efficacy and Safety of a Hospital Walking Program for Older Adults
Acute Disease
Primary: Falls — 0; 2 participants — p=<.05
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=132 Impact of a Mobility Program
Hospitalization
Primary: Life-Space Assessment Score — 57.8; 59.6 score on a scale — p=0.02
N/A N=9 Bracing for Walking in Parkinson's Disease
Gait Disorders, Neurologic · Parkinson Disease
Primary: Change in Gait Capacity as Assessed b 6-Minute Walk Test — 235.7; 150.0 Feet
Phase 1 N=23 Spinal Excitation to Enhance Mobility
Aging
Primary: Walking Speed Change From Baseline — .054; .078; .085; .039 meters/second
N/A N=12 Walk Assist Device to Improve Community Ambulation
Stroke
Primary: Change in Six Minute Walk Test Between Device Turned ON and OFF - Distance Traveled — 837.1; 804.8 feet
N/A N=33 Improving Mobility in Peripheral Artery Disease Using an Ankle Foot Orthosis
Peripheral Artery Disease
Primary: Maximum Walking Time From the Gardner Graded Treadmill Protocol — 117.7; 197.5; 188; 339.9 Seconds
N/A N=20 Multimodel Exercise and Weight Loss in Older Obese Veterans With Dysmobility
Obesity · Dysmobility
Primary: Change in 6 Minute Walk Distance — 1137; 1195 feet — p=0.03
N/A N=12 Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments
Mild Cognitive Impairment · Cognitive Decline · Gait Disorders in Old Age
Primary: Change in 4-Meter Gait Speed (Section 2 of the Short Physical Performance Battery) — 0.79; 0.82; 0.79 Meters/Second
N/A N=10 Improving Walking in Peripheral Artery Disease
Peripheral Artery Disease
Primary: Changes in Walking Distance After Three-months Intervention — 289.68; 262.95 meters
N/A N=140 Walking and mHealth to Increase Participation in Parkinson Disease
Parkinson Disease
Primary: Walking Activity — -207.59; -135.24 change in average daily steps — p=.89
N/A N=36 Amplify Gait to Improve Locomotor Engagement in Spinal Cord Injury
Incomplete Spinal Cord Injury
Primary: Functional Gait Assessment (FGA) — 15.22; 14.22; 19.38; 18.13 score on a scale — p=<0.001
N/A N=17 "Can A Prescribed Walking Program With or Without Monitoring Impact Dizziness in the Older Adults?"
Dizziness
Primary: Modified Clinical Test of Sensory Integration for Balance (mCTSIB) — 115.98; 97.4; 110.15; 107.23 seconds — p=.640
N/A N=6 Basic Mobility and Balance Performance of Low Active Transfemoral Prosthesis Users With a Powered Prosthetic Knee
Prosthesis User · Amputation
Primary: Timed Up and Go Test (TUG Test) — 13.3; 16.8 seconds
N/A N=385 Improving Patient Walking During Hospitalization
Early Mobility · Older Adults · Hospital Acquired Condition
Primary: Aim 1: Change in Gait Speed — 0.67; 0.73; 0.73; 0.77 m/s — p=0.674
N/A N=73 Exoskeletal-assisted Walking to Improve Mobility, Bowel Function and Cardio-Metabolic Profiles in Persons With SCI
Spinal Cord Injury · Paraplegia · Tetraplegia
Primary: 10meter Walk Test — 46; 48 Participants
N/A N=45 Robotic Walking Device to Improve Mobility in Parkinson's Disease
Parkinson Disease
Primary: Gait Velocity — 1.25; 1.25 Meters per second
N/A N=424 On the Move: Optimizing Participation in Group Exercise
Physical Disability
Primary: Change in Self-reported Overall Function From Baseline to 12 Weeks — 0.4; -0.6; -1.37; -0.32 units on a scale — p=0.2691
N/A N=31 Physical Activity Behavior Change for Older Adults After Dysvascular Amputation
Amputation · Diabetes Mellitus, Type 2 · Peripheral Artery Disease
Primary: Retention Rate — 14; 13 Participants
N/A N=290 Effects of Ambulation During First Stage of Labour on Maternal and Neonatal Outcomes
Labor Pain
Primary: Duration of the First Stage of Labour — 548.337; 719.585 minutes
N/A N=22 Machines Assisting Recovery From Stroke
Cerebrovascular Disease; Sequelae
Primary: 10 m Walk Test — 0.64; 0.79 m/s
N/A N=10 Functional Outcomes in Dysvascular Transfemoral Amputees
Transfemoral Amputation · Unilateral Traumatic Amputation of Leg at or Above Knee
Primary: Change in Community Physical Activity as Measured by GPS — 1749; 1625; 1257 Steps per day
N/A N=10 Powered Hip Exoskeleton Assistance Study
Lower Limb Injury
Primary: Self-Selected Walking Speed Using Hip Exoskeleton Assistance Across Different Locomotion Modes — 1.14; 1.26; 1.26; 0.61 meters per second — p=0.9547
N/A N=19 The ReWalk Exoskeletal Walking System for Persons With Paraplegia
Paraplegia
Primary: Count to Achieve Mobility Skills — 9; 3; 0; 10 Participants
N/A N=93 Comparing 6-Minute Walk Tests for Ambulatory Oxygen Assessment
Respiratory Disease
Primary: Average Drop in SpO2 From Baseline to Nadir — 6; 5 SpO2 (%) — p=<0.01
N/A N=23 Falls in Older Persons With Limb Loss
Amputation · Elderly
Primary: Foot's Height During the Swing Phase of Walking (i.e., Foot Clearance) Measured in Centimeter — 6.1; 5.5; 6.1; 5.7 cm
N/A N=16 Effects of Wearing a Powered Ankle-Foot Prosthesis on Amputee Walking
Traumatic Amputation of Lower Extremity
Primary: Metabolic Cost of Transport — 4.76; 4.57; 4.68; 4.11 J/Nm
N/A N=5 Assistive Hip Exoskeleton Study for Stroke
Lower Limb Injury · Stroke
Primary: Overground Self-Selected Walking Speed Using Hip Exoskeleton Assistance — 87.03; 87.96; 90.4; 93.05 centimeters per second — p=0.000005
N/A N=30 LifeWalker Upright Walker vs. Conventional Rollator Walker and Predicate Device
Back Pain
Primary: 6 Minute Walk Test — 245.2; 234.7; 233.9 meters
N/A N=48 Intelligent and Adaptive Control Applied to Powered Walkers
Cerebral Palsy
Primary: Metabolic Cost (Oxygen Consumption) — 11.0; 12.7; 7.0; 9.4 J/kg — p=< 0.001
Early Phase 1 N=6 Evaluating Wearable Robotic Assistance on Gait
Cerebral Palsy
Primary: The Metabolic Energy Required to Walk — 2.42; -2.14 % change pre vs post gait training — p=0.204